{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:53:23Z","timestamp":1791039203453,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1007\/s11010-006-1153-9","type":"journal-article","created":{"date-parts":[[2005,11,29]],"date-time":"2005-11-29T14:03:00Z","timestamp":1133272980000},"page":"31-37","source":"Crossref","is-referenced-by-count":53,"title":["Prevention of doxorubicin-induced cardiotoxicity by melatonin"],"prefix":"10.1007","volume":"282","author":[{"given":"Eser","family":"\u00d6z","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Erba\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Sel\u00e7uk","family":"S\u00fcr\u00fcc\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersel","family":"D\u00fczg\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"1153_CR1","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1096\/fasebj.4.13.2210154","volume":"4","author":"RD Olson","year":"1990","unstructured":"Olson RD, Mushlin PS: Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J 4: 3076\u20133086, 1990","journal-title":"FASEB J"},{"issue":"17","key":"1153_CR2","first-page":"4766","volume":"48","author":"S Rajagopalan","year":"1988","unstructured":"Rajagopalan S, Politi PM, Sinha BK, Myers E: Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity. Cancer Res 48 (17): 4766\u20134769, 1988","journal-title":"Cancer Res"},{"key":"1153_CR3","first-page":"H989","volume":"261","author":"V Lee","year":"1991","unstructured":"Lee V, Randhawa AK, Singal PK: Adriamycin-induced myocardial dysfunction in vitro is mediated by free radicals. Am J Physiol 261: H989\u2013995, 1991","journal-title":"Am J Physiol"},{"key":"1153_CR4","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/0024-3205(95)02036-I","volume":"57","author":"NA Sarvazyan","year":"1995","unstructured":"Sarvazyan NA, Askari A, Huang WH: Effects of doxorubicin on cardiomyocytes with reduced level of superoxide dismutase. Life Sci 57: 1003\u20131010, 1995","journal-title":"Life Sci"},{"key":"1153_CR5","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0022-2828(95)90074-8","volume":"27","author":"PK Singal","year":"1995","unstructured":"Singal PK, Siveski-Iliskovic N, Hill M, Thomas TP, Li T: Combination therapy with probucol prevents adriamycin-induced cardiomyopathy. J Mol Cell Cardiol 27: 1055\u20131063, 1995","journal-title":"J Mol Cell Cardiol"},{"key":"1153_CR6","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/j.2042-7158.1996.tb06007.x","volume":"48","author":"J Vora","year":"1996","unstructured":"Vora J, Khaw B A, Narula J, Boroujerdi M: Protective effect of butylated hydroxyanisole on adriamycin induced cardiotoxicty. J Pharm Pharmacol 48: 940\u2013944, 1996","journal-title":"J Pharm Pharmacol"},{"key":"1153_CR7","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0024-3205(97)00030-1","volume":"60","author":"R Reiter","year":"1997","unstructured":"Reiter R, Tang L, Garcia JJ, Munoz-Hoyos A: Pharmalogical actions of melatonin in oxygen radical pathophysiology. Life Sci 60: 2255\u20132271, 1997","journal-title":"Life Sci"},{"key":"1153_CR8","first-page":"1329","volume":"18","author":"B Neri","year":"1998","unstructured":"Neri B, de Leonardis V, Gemelli MT, di Loro F, Mottola A, Ponchietti R, Raugei A, Cini G: Melatonin as biological response modifier in cancer patients. Anticancer Res 18: 1329\u20131332, 1998","journal-title":"Anticancer Res"},{"key":"1153_CR9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1600-079X.1993.tb00498.x","volume":"14","author":"B Poeggeler","year":"1993","unstructured":"Poeggeler B, Reiter RJ, Tan DX, Chen LD, Manchester LC: Melatonin, hydroxy radical-mediated oxidative damage, and aging: A hypothesis. J Pineal Res 14: 151\u2013168, 1993","journal-title":"J Pineal Res"},{"key":"1153_CR10","doi-asserted-by":"crossref","first-page":"PL 271","DOI":"10.1016\/0024-3205(94)00666-0","volume":"55","author":"C Pieri","year":"1994","unstructured":"Pieri C, Marra M, Moroni F, Recchioni R, Marcheselli F: Melatonin: A peroxyl radical scavenger more effective than vitamin E. Life Sci 55:PL 271\u2013276, 1994","journal-title":"Life Sci"},{"key":"1153_CR11","doi-asserted-by":"crossref","first-page":"PL 169","DOI":"10.1016\/S0024-3205(97)00008-8","volume":"60","author":"E Gilad","year":"1997","unstructured":"Gilad E, Cuzzocrea S, Zingarelli B, Salzman AL, Szabo C: Melatonin is a scavenger of peroxynitrite. Life Sci 60: PL 169\u2013174, 1997","journal-title":"Life Sci"},{"key":"1153_CR12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1600-079X.1997.tb00312.x","volume":"22","author":"ZR Li","year":"1997","unstructured":"Li ZR, Reiter RJ, Fujimori O, Oh CS, Duan YP: Cataractogenesis and lipid peroxidation in newborn rats treated with buthionine sulfoximine: Preventive actions of melatonin. J Pineal Res 22 : 117\u2013123, 1997","journal-title":"J Pineal Res"},{"key":"1153_CR13","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0008-6363(96)00030-2","volume":"31","author":"S Bertuglia","year":"1996","unstructured":"Bertuglia S, Marchiafava PL, Colantuoni A: Melatonin prevents ischemia reperfusion injury in hamster cheek pouch microcirculation. Cardiovasc Res 31: 947\u2013952, 1996","journal-title":"Cardiovasc Res"},{"key":"1153_CR14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1011903904056","volume":"15","author":"DJ Duncker","year":"2001","unstructured":"Duncker DJ, Verdouw PD: Has melatonin a future as a cardioprotective agent? Cardiovasc Drugs Ther 15: 205\u2013207, 2001","journal-title":"Cardiovasc Drugs Ther"},{"key":"1153_CR15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1034\/j.1600-079X.2003.00084.x","volume":"35","author":"E Sahna","year":"2003","unstructured":"Sahna E, Parlakp\u0131 nar H, \u00d6zer MK, \u00d6zt\u00fcrk F, \u00d6zu\u011furlu F, Acet A: Melatonin protects against myocardial doxorubicin toxicity in rats: Role of physiological concentrations. J Pineal Res 35: 257\u2013261, 2003","journal-title":"J Pineal Res"},{"key":"1153_CR16","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.bmc.2004.10.066","volume":"13","author":"HH Ahmed","year":"2005","unstructured":"Ahmed HH, Mannaa F, Elmegeed GA, Doss SH: Cardioprotective activity of melatonin and its novel synthesized derivates on doxorubicin-induced cardiotoxicity. Bioorg Med Chem 13: 1847\u20131857, 2005","journal-title":"Bioorg Med Chem"},{"key":"1153_CR17","first-page":"181","volume":"106","author":"\u00d6 Timlio\u011flu","year":"1999","unstructured":"Timlio\u011flu \u00d6, Kutsal \u015e, \u00d6zkur M, Uluo\u011flu \u00d6, Ar\u0131 c\u0131 o\u011flu A, \u00c7evik C, D\u00fczg\u00fcn E, Sancak B, Poyraz A: The effect of EGb 761 on the doxorubicin cardiomyopathy. Res Commun Mol Pathol Pharmacol 106: 181\u2013192, 1999","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"1153_CR18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000022065","volume":"45","author":"KG Akbulut","year":"1999","unstructured":"Akbulut KG, G\u00f6n\u00fcl B, Akbulut H: Differential effects of pharmacological doses of melatonin on malondialdehyde and glutathione levels in young and old rats. Gerontology. 45: 67\u201371, 1999","journal-title":"Gerontology."},{"key":"1153_CR19","doi-asserted-by":"crossref","first-page":"G573","DOI":"10.1152\/ajpcell.1992.263.3.C573","volume":"263","author":"H Kurtel","year":"1992","unstructured":"Kurtel H, Granger D N, Tso P, Grisham MB: Vulnerability of intestinal interstitial fluid the oxidant stres. Am J Physiol 263: G573\u2013578, 1992","journal-title":"Am J Physiol"},{"key":"1153_CR20","first-page":"520","volume":"123","author":"A Casini","year":"1986","unstructured":"Casini A, Ferrali M, Pompella A, Maellaro E, Comborti M: Lipid reroxidation and cellular damage in extrahepatic tissues of bromobenzene intoxicated mice. Am J Pathol 123: 520\u2013531, 1986","journal-title":"Am J Pathol"},{"key":"1153_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3835(06)80003-0","volume":"98","author":"O Kozluca","year":"1995","unstructured":"Kozluca O, Olcay E, S\u00fcr\u00fcc\u00fc S, G\u00fcran Z, Kulaks\u0131 z T, \u00dcskent N: Prevention of doxorubicin induced cardiotoxicity by catechin. Cancer Lett 98: 1\u20136, 1995","journal-title":"Cancer Lett"},{"key":"1153_CR22","doi-asserted-by":"crossref","first-page":"H254","DOI":"10.1152\/ajpheart.01023.2001","volume":"283","author":"X Liu","year":"2002","unstructured":"Liu X, Chen Z, Chua CC, Ma YS, Youngberg GA, Hamdy R, Chua BH: Melatonin as an effective protector against doxorubicin-induced cardiotoxicity. Am J Physiol Heart Circ Physiol 283: H254\u2013263, 2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1153_CR23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1034\/j.1600-079X.2001.310104.x","volume":"31","author":"MT Agapito","year":"2001","unstructured":"Agapito MT, Antolin Y, del Brio MT, Lopez-Burillo S, Pablos MI, Recio JM: Protective effect of melatonin against adriamycin toxicity in the rat. J Pineal Res 31: 23\u201330, 2001","journal-title":"J Pineal Res"},{"key":"1153_CR24","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0024-3205(00)00990-5","volume":"68","author":"MF Xu","year":"2001","unstructured":"Xu MF, Tang PL, Qian ZM, Ashraf M: Effects by doxorubicin on the myocardium are mediated by oxygen free radicals. Life Sci 68: 889\u2013901, 2001","journal-title":"Life Sci"},{"key":"1153_CR25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1172\/JCI109642","volume":"65","author":"JH Doroshow","year":"1980","unstructured":"Doroshow JH, Locker GY, Myers CE: Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin. J Clin Invest 65: 128\u2013135, 1980","journal-title":"J Clin Invest"},{"key":"1153_CR26","doi-asserted-by":"crossref","first-page":"PL 271","DOI":"10.1016\/0024-3205(94)00666-0","volume":"55","author":"C Pieri","year":"1994","unstructured":"Pieri C, Marra M, Moroni F, Recchioni R, Marcheselli F: Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 55: PL 271\u2013276, 1994","journal-title":"Life Sci"},{"key":"1153_CR27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0149-7634(05)80016-8","volume":"17","author":"R Hardeland","year":"1993","unstructured":"Hardeland R, Reiter RJ, Poeggeler B, Tan DX: The significance of the metabolism of the neurohormone melatonin: antioxidative protection and formation of bioactive substances. Neurosci Biobehav Rev 17: 347\u2013357, 1993","journal-title":"Neurosci Biobehav Rev"},{"key":"1153_CR28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0163-7258(91)90076-X","volume":"51","author":"A Meister","year":"1991","unstructured":"Meister A: Glutathione deficiency produced by inhibition of it's synthesis and it's reversal : applications in research and therapy. Pharmacol Ther 51: 155\u2013194, 1991","journal-title":"Pharmacol Ther"},{"key":"1153_CR29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1034\/j.1600-079X.2003.00079.x","volume":"35","author":"P Dziegiel","year":"2003","unstructured":"Dziegiel P, Murawska-Cialowicz E, Jethon Z, Januszewska L, Podhorska-Okolow M, Surowiak P, Zawadzki M, Rabczynski J, Zabel M: Melatonin stimulates the activity of protective antioxidative enzymes in myocardial cells of rats in the course of doxorubicin intoxication. J Pineal Res 35: 183\u2013187, 2003","journal-title":"J Pineal Res"},{"key":"1153_CR30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1034\/j.1600-0773.2003.930301.x","volume":"93","author":"KB Wallace","year":"2003","unstructured":"Wallace KB: Doxorubicin-induced cardiac mitochondrionopathy. Pharmacol Toxicol 93: 105\u2013115, 2003","journal-title":"Pharmacol Toxicol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-006-1153-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-006-1153-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-006-1153-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T02:06:02Z","timestamp":1559354762000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-006-1153-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":30,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["1153"],"URL":"https:\/\/doi.org\/10.1007\/s11010-006-1153-9","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}